Earnings Per Share, Basic in USD/shares of REGENERX BIOPHARMACEUTICALS INC from Q3 2013 to Q1 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
REGENERX BIOPHARMACEUTICALS INC quarterly/annual Earnings Per Share, Basic history and change rate from Q3 2013 to Q1 2023.
  • REGENERX BIOPHARMACEUTICALS INC Earnings Per Share, Basic for the quarter ending 31 Mar 2023 was 0 USD/shares.
  • REGENERX BIOPHARMACEUTICALS INC Earnings Per Share, Basic for the twelve months ending 31 Mar 2023 was 0 USD/shares, unchanged year-over-year.
  • REGENERX BIOPHARMACEUTICALS INC annual Earnings Per Share, Basic for 2022 was -0.01 USD/shares, unchanged from 2021.
  • REGENERX BIOPHARMACEUTICALS INC annual Earnings Per Share, Basic for 2021 was -0.01 USD/shares, unchanged from 2020.
  • REGENERX BIOPHARMACEUTICALS INC annual Earnings Per Share, Basic for 2020 was -0.01 USD/shares, unchanged from 2019.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

REGENERX BIOPHARMACEUTICALS INC Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $0 $0 $0 0% 01 Oct 2022 31 Dec 2022 10-K 11 Apr 2023
Q3 2022 $0 $0 $0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $0 $0 $0 01 Apr 2022 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 $0 $0 $0 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $0 $0 $0 0% 01 Oct 2021 31 Dec 2021 10-K 11 Apr 2023
Q3 2021 $0 $0 $0 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $0 $0 $0 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $0 $0 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $0 $0 $0 0% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $0 $0 $0 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $0 $0 $0 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $0 $0 $0 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $0 $0 $0 0% 01 Oct 2019 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 $0 $0 $0 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $0 $0 $0 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $0 $0 +$0.01 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $0 $0 $0 -200% 01 Oct 2018 31 Dec 2018 10-K 20 Mar 2020
Q3 2018 $0 $0 +$0.01 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $0 $0 $0 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $0 $0 $0 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $0 $0.01 +$0.01 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 $0 $0 $0 -200% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $0 $0 $0 -100% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $0 $0 +$0.03 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 $0 $0 01 Oct 2016 31 Dec 2016 10-K 29 Mar 2018
Q3 2016 $0.01 +$0.02 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 $0.02 +$0.04 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017
Q1 2016 $0 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q3 2015 $0 $0 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 $0 01 Apr 2015 30 Jun 2015 10-Q 22 Aug 2016
Q3 2014 $0 $0 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q3 2013 $0 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014

REGENERX BIOPHARMACEUTICALS INC Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 $0 0% 01 Jan 2022 31 Dec 2022 10-K 11 Apr 2023
2021 $0 $0 0% 01 Jan 2021 31 Dec 2021 10-K 11 Apr 2023
2020 $0 $0 0% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022
2019 $0 +$0.01 +50% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2021
2018 $0 $0 01 Jan 2018 31 Dec 2018 10-K 20 Mar 2020
2017 $0 $0 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 $0 +$0.05 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018
2015 $0 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.